- freely available
Pandemic Influenza Vaccines – The Challenges
AbstractRecent years’ enzootic spread of highly pathogenic H5N1 virus among poultry and the many lethal zoonoses in its wake has stimulated basic and applied pandemic vaccine research. The quest for an efficacious, affordable and timely accessible pandemic vaccine has been high on the agenda. When a variant H1N1 strain of swine origin emerged as a pandemic virus, it surprised many, as this subtype is well-known to man as a seasonal virus. This review will cover some difficult vaccine questions, such as the immunological challenges, the new production platforms, and the limited supply and global equity issues.
Share & Cite This Article
Export to BibTeX | EndNote
MDPI and ACS Style
Haaheim, L.R.; Madhun, A.S.; Cox, R. Pandemic Influenza Vaccines – The Challenges. Viruses 2009, 1, 1089-1109.View more citation formats
Haaheim LR, Madhun AS, Cox R. Pandemic Influenza Vaccines – The Challenges. Viruses. 2009; 1(3):1089-1109.Chicago/Turabian Style
Haaheim, Lars R.; Madhun, Abdullah S.; Cox, Rebecca. 2009. "Pandemic Influenza Vaccines – The Challenges." Viruses 1, no. 3: 1089-1109.